Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Jonasch

Showing results (81-90 of 271) with videos related to

Pageof 28
Sort By:
Cancer Investigation|June 28, 2008
A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytomaThereasa A Rich, Eric Jonasch, Surena Matin, et al.
The Journal of Urology|September 18, 2010
Radio frequency ablation of renal tumors in patients with metastatic renal cell carcinomaJose A Karam, Kamran Ahrar, Christopher G Wood, et al.
Communications Biology|October 25, 2019
Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptakeSong Yi Ko, WonJae Lee, Hilary A Kenny, et al.
American Journal of Clinical Oncology|January 30, 2013
Axitinib for the treatment of metastatic renal cell carcinoma: recommendations for therapy management to optimize outcomesJames Larkin, Mayer Fishman, Laura Wood, et al.
Practical Radiation Oncology|May 1, 2018
Renal cell carcinoma brain metastasis with pseudoprogression and radiation necrosis on nivolumab after previous treatment with stereotactic radiosurgery: An illustrative case report and review of the literatureGary D Lewis, Eric Jonasch, Amishix Y Shah, et al.
The Journal of Urology|February 14, 2007
Cytoreductive nephrectomy in the elderly patient: the M. D. Anderson Cancer Center experienceA Karim Kader, Pheroze Tamboli, Tony Luongo, et al.
BJU International|September 24, 2013
Mammalian target of rapamycin (mTOR) inhibitor-associated non-infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomesBradley J Atkinson, Diana H Cauley, Chaan Ng, et al.
Cancer|May 20, 2008
Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinomaEric Jonasch, Walter M Stadler, Ronald M Bukowski, et al.
Proteome Science|September 26, 2012
An efficient procedure for protein extraction from formalin-fixed, paraffin-embedded tissues for reverse phase protein arraysHuifang Guo, Wenbin Liu, Zhenlin Ju, et al.
JCO Precision Oncology|February 27, 2023
Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort StudyFrancesco Gatto, Sinisa Bratulic, Eric Jonasch, et al.
Pageof 28

Showing results (81-90 of 271) with videos related to

Sort By:
Pageof 28
Cancer Investigation|June 28, 2008
A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytomaThereasa A Rich, Eric Jonasch, Surena Matin, et al.
The Journal of Urology|September 18, 2010
Radio frequency ablation of renal tumors in patients with metastatic renal cell carcinomaJose A Karam, Kamran Ahrar, Christopher G Wood, et al.
Communications Biology|October 25, 2019
Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptakeSong Yi Ko, WonJae Lee, Hilary A Kenny, et al.
American Journal of Clinical Oncology|January 30, 2013
Axitinib for the treatment of metastatic renal cell carcinoma: recommendations for therapy management to optimize outcomesJames Larkin, Mayer Fishman, Laura Wood, et al.
Practical Radiation Oncology|May 1, 2018
Renal cell carcinoma brain metastasis with pseudoprogression and radiation necrosis on nivolumab after previous treatment with stereotactic radiosurgery: An illustrative case report and review of the literatureGary D Lewis, Eric Jonasch, Amishix Y Shah, et al.
The Journal of Urology|February 14, 2007
Cytoreductive nephrectomy in the elderly patient: the M. D. Anderson Cancer Center experienceA Karim Kader, Pheroze Tamboli, Tony Luongo, et al.
BJU International|September 24, 2013
Mammalian target of rapamycin (mTOR) inhibitor-associated non-infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomesBradley J Atkinson, Diana H Cauley, Chaan Ng, et al.
Cancer|May 20, 2008
Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinomaEric Jonasch, Walter M Stadler, Ronald M Bukowski, et al.
Proteome Science|September 26, 2012
An efficient procedure for protein extraction from formalin-fixed, paraffin-embedded tissues for reverse phase protein arraysHuifang Guo, Wenbin Liu, Zhenlin Ju, et al.
JCO Precision Oncology|February 27, 2023
Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort StudyFrancesco Gatto, Sinisa Bratulic, Eric Jonasch, et al.
Pageof 28